Dexcom (DXCM) Total Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) has reported Total Non-Current Liabilities for 17 consecutive years, with $3.7 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 19.97% year-over-year to $3.7 billion in Q2 2026; TTM through Jun 2026 was $3.7 billion, a 19.97% decrease from a year earlier, with the FY2025 full-year figure at $3.5 billion, down 18.36% from the prior year.
• Total Non-Current Liabilities was $3.7 billion for Q2 2026 at Dexcom, up from $3.5 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $4.6 billion in Q3 2025 and troughed at $2.8 billion in Q1 2022.
• A 5-year average of $3.8 billion and a median of $4.1 billion in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities jumped 60.28% in 2023 and retreated 19.97% in 2026, its largest moves.
• Over 5 years, Total Non-Current Liabilities stood at $3.1 billion in 2022, then increased by 29.98% to $4.1 billion in 2023, then climbed by 4.02% to $4.2 billion in 2024, then slipped by 18.36% to $3.5 billion in 2025, then advanced by 6.55% to $3.7 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $3.7 billion (Q2 2026), $3.5 billion (Q1 2026), and $3.5 billion (Q4 2025), per Business Quant data.